271 related articles for article (PubMed ID: 34144215)
1. Ovarian cancer modulates the immunosuppressive function of CD11b
Udumula MP; Sakr S; Dar S; Alvero AB; Ali-Fehmi R; Abdulfatah E; Li J; Jiang J; Tang A; Buekers T; Morris R; Munkarah A; Giri S; Rattan R
Mol Metab; 2021 Nov; 53():101272. PubMed ID: 34144215
[TBL] [Abstract][Full Text] [Related]
2. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b
Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson PJ; Akira S; Majima M
Biomed Pharmacother; 2020 Jan; 121():109581. PubMed ID: 31715374
[TBL] [Abstract][Full Text] [Related]
3. Tumor refractoriness to endostatin anti-angiogenesis is associated with the recruitment of CD11b+Gr1+ myeloid cells and inflammatory cytokines.
Zhang H; Wang Z; Peng Q; Liu YY; Zhang W; Wu L; Wang X; Luo F
Tumori; 2013; 99(6):723-33. PubMed ID: 24503797
[TBL] [Abstract][Full Text] [Related]
4. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
[TBL] [Abstract][Full Text] [Related]
5. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
[TBL] [Abstract][Full Text] [Related]
6. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.
Fujikawa Y; Sendo S; Del Peral Fanjul A; Yamada H; Uto K; Yamamoto Y; Nagamoto T; Morinobu A; Saegusa J
Front Immunol; 2024; 15():1168323. PubMed ID: 38566990
[TBL] [Abstract][Full Text] [Related]
8. [Mesenchymal stem cells promote mouse breast tumor progression by inducing the suppressive function of myeloid-derived CD11b⁺ Gr1⁺ cells].
Hu X; Luo Y; Zhou Y; Zhao D; Wu W; Han Z; Feng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):785-8. PubMed ID: 25108426
[TBL] [Abstract][Full Text] [Related]
9. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
[TBL] [Abstract][Full Text] [Related]
10. Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.
Brandenburg S; Turkowski K; Mueller A; Radev YT; Seidlitz S; Vajkoczy P
Immunol Res; 2017 Jun; 65(3):757-768. PubMed ID: 28367602
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.
Catena R; Bhattacharya N; El Rayes T; Wang S; Choi H; Gao D; Ryu S; Joshi N; Bielenberg D; Lee SB; Haukaas SA; Gravdal K; Halvorsen OJ; Akslen LA; Watnick RS; Mittal V
Cancer Discov; 2013 May; 3(5):578-89. PubMed ID: 23633432
[TBL] [Abstract][Full Text] [Related]
12. The role of CCR5 in directing the mobilization and biological function of CD11b
Karin N; Razon H
Cancer Immunol Immunother; 2018 Dec; 67(12):1949-1953. PubMed ID: 30232521
[TBL] [Abstract][Full Text] [Related]
13. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
15. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.
Ryzhov S; Novitskiy SV; Goldstein AE; Biktasova A; Blackburn MR; Biaggioni I; Dikov MM; Feoktistov I
J Immunol; 2011 Dec; 187(11):6120-9. PubMed ID: 22039302
[TBL] [Abstract][Full Text] [Related]
16. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.
Matsui A; Yokoo H; Negishi Y; Endo-Takahashi Y; Chun NA; Kadouchi I; Suzuki R; Maruyama K; Aramaki Y; Semba K; Kobayashi E; Takahashi M; Murakami T
PLoS One; 2012; 7(8):e44080. PubMed ID: 22952881
[TBL] [Abstract][Full Text] [Related]
17. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
19. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response.
Brudecki L; Ferguson DA; McCall CE; El Gazzar M
Infect Immun; 2012 Jun; 80(6):2026-34. PubMed ID: 22451518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
